Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction

Biological Chemistry

Volumn 385, Issue 8, 2004, Pages 697-710

  Sebald, Walter ^a   Nickel, Joachim ^a   Zhang, Jin Li ^a   Mueller, Thomas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Binding determinants; Functional epitope; Modulator protein; Muteins; Receptor ectodomain; TGF like protein

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; EPITOPE; NOGGIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2;

AMINO ACID SEQUENCE; DRUG DESIGN; HUMAN; HYDROPHOBICITY; MOLECULAR RECOGNITION; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; REVIEW; TISSUE REGENERATION;

EID: 4544286802     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2004.086     Document Type: Review

References (129)

1. Abreu, J. G., Ketpura, N. I., Reversade, B., and De Robertis, E. M. (2002). Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat. Cell. Biol 4, 599-604.
2. Avsian-Kretchmer, O., and Hsueh, A. J. (2004). Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists. Mol. Enclocrinol. 18, 1-12.
3. Balemans, W., and Van Hul, W. (2002). Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev. Biol. 250, 231-250.
4. Baur, S. T., Mai, J. J., and Dymecki, S. M. (2000). Combinatorial signaling through BMP receptor IB and GDF5: shaping of the distal mouse limb and the genetics of distal limb diversity. Development 127, 605-619.
5. Bernat, B., Pal, G., Sun, M., and Kossiakoff, A. A. (2003). Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization. Proc. Natl. Acad. Sci. USA 100, 952-957.
6. Blessing, M., Schirmacher, P., and Kaiser, S. (1996). Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions. J. Cell Biol. 135, 227-239.
7. Boesen, C. C., Radaev, S., Motyka, S. A., Patamawenu, A., and Sun, P. D. (2002). The 1.1 Å crystal structure of human TGF-β type II receptor ligand binding domain. Structure 10, 913-919.
8. Branton, M. H., and Kopp, J. B. (1999). TGF-β and fibrosis. Microbes Infect. 1, 1349-1365.
9. Canalis, E., Economides, A. N., and Gazzerro, E. (2003). Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr. Rev. 24, 218-235.
10. Clackson, T., Ultsch, M. H., Wells, J. A., and de Vos, A. M. (1998). Structural and functional analysis of the 1:1 growth hormone: receptor complex reveals the molecular basis for receptor affinity. J. Mol. Biol. 277, 1111-1128.
11. Clackson, T., and Wells, J. A. (1995). A hot spot of binding energy in a hormone-receptor interface. Science 267, 383-386.
12. Cunningham, B. C., and Wells, J. A. (1993). Comparison of a structural and a functional epitope. J. Mol. Biol. 234, 554-563. [Erratum published in J. Mol. Biol. 237 (1994), p. 513]
13. Daopin, S., Piez, K. A., Ogawa, Y., and Davies, D. R. (1992). Crystal structure of transforming growth factor-β2: an unusual fold for the superfamily. Science 257, 369-373.
14. de Vos, A. M., Ultsch, M., and Kossiakoff, A. A. (1992). Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255, 306-312.
15. Deep, S., Walker, K. P., 3rd, Shu, Z., and Hinck, A. P. (2003). Solution structure and backbone dynamics of the TGFβ type II receptor extracellular domain. Biochemistry 42, 10126-10139.
16. DiLeone, R. J., Marcus, G. A., Johnson, M. D., and Kingsley, D. M. (2000). Efficient studies of long-distance Bmp5 gene regulation using bacterial artificial chromosomes. Proc. Natl. Acad. Sci. USA 97, 1612-1617.
17. Dong, J., Albertini, D. F., Nishimori, K., Kumar, T. R., Lu, N., and Matzuk, M. M. (1996). Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383, 531-535.
18. Duncan, M. R., Frazier, K. S., Abramson, S., Williams, S., Klapper, H., Huang, X., and Grotendorst, G. R. (1999). Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J. 13, 1774-1786.
19. Dunn, N. R., and Hogan, B. L. (2001). How does the mouse get its trunk? Nat. Genet. 27, 351-352.
20. Ebisawa, T., Tada, K., Kitajima, I., Tojo, K., Sampath, T. K., Kawabata, M., Miyazono, K., and Imamura, T. (1999). Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J. Cell Sci. 112, 3519-3527.
21. Eigenbrot, C., and Gerber, N. (1997). X-ray structure of glial cell-derived neurotrophic factor at 1.9 Å resolution and implications for receptor binding. Nat. Struct. Biol. 4, 435-438.
22. Eketjall, S., Fainzilber, M., Murray Rust, J., and Ibanez, C. F. (1999). Distinct structural elements in GDNF mediate binding to GFRα1 and activation of the GFRα1-c-Ret receptor complex. EMBO J. 18, 5901-5910.
23. Fox, K. M., Dias, J. A., and Van Roey, P. (2001). Three-dimensional structure of human follicle-stimulating hormone. Mol. Endocrinol. 15, 378-389.
24. Furthauer, M., Thisse, B., and Thisse, C. (1999). Three different noggin genes antagonize the activity of bone morphogenetic proteins in the zebrafish embryo. Dev. Biol. 214, 181-196.
25. Galloway, S. M., McNatty, K. P., Cambridge, L. M., Laitinen, M. P., Juengel, J. L., Jokiranta, T. S., McLaren, R. J., Luiro, K., Dodds, K. G., Montgomery, G. W. et al. (2000). Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat. Genet. 25, 279-283.
26. Garcia Abreu, J., Coffinier, C., Larrain, J., Oelgeschlager, M., and De Robertis, E. M. (2002). Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene 287, 39-47.
27. Gilboa, L., Wells, R. G., Lodish, H. F., and Henis, Y. I. (1998). Oligomeric structure of type I and type II transforming growth factor β receptors: homodimers form in the ER and persist at the plasma membrane. J. Cell Biol. 140, 767-777.
28. Gilboa, L., Nohe, A., Geissendorfer, T., Sebald, W., Henis, Y. I., and Knaus, P. (2000). Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol. Biol. Cell 11, 1023-1035.
29. Gray, P. C., Bilezikjian, L. M., and Vale, W. (2002). Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan. Mol. Cell. Endocrinol. 188, 254-260.
30. Greenwald, J., Fischer, W. H., Vale, W. W., and Choe, S. (1999). Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase. Nat. Struct. Biol. 6, 18-22.
31. Greenwald, J., Groppe, J., Gray, P., Wiater, E., Kwiatkowski, W., Vale, W., and Choe, S. (2003). The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol. Cell 11, 605-617.
32. Griffith, D. L., Keck, P. C., Sampath, T. K., Rueger, D. C., and Carlson, W. D. (1996). Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor β superfamily. Proc. Natl. Acad. Sci. USA 93, 878-883.
33. Groppe, J., Greenwald, J., Wiater, E., Rodriguez-Leon, J., Economides, A. N., Kwiatkowski, W., Affolter, M., Vale, W. W., Belmonte, J. C., and Choe, S. (2002). Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420, 636-642.
34. Grotendorst, G. R. (1997). Connective tissue growth factor: a mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev. 8, 171-179.
35. Hart, P. J., Deep, S., Taylor, A. B., Shu, Z., Hinck, C. S., and Hinck, A. P. (2002). Crystal structure of the human TβR2 ectodomain-TGF-β3 complex. Nat. Struct. Biol. 9, 203-208.
36. Hatta, T., Konishi, H., Katoh, E., Natsume, T., Ueno, N., Kobayashi, Y., and Yamazaki, T. (2000). Identification of the ligand-binding site of the BMP type IA receptor for BMP-4. Biopolymers 55, 399-406.
37. He, S., Jin, M. L., Worpel, V., and Hinton, D. R. (2003). A role for connective tissue growth factor in the pathogenesis of choroidal neovascularization. Arch. Ophthalmol. 121, 1283-1288.
38. Heldin, C. H. (1995). Dimerization of cell surface receptors in signal transduction. Cell 80, 213-223.
39. Heldin, C. H., and Ostman, A. (1996). Ligand-induced dimerization of growth factor receptors: variations on the theme. Cytokine Growth Factor Rev. 7, 3-10.
40. Heldin, C. H., Miyazono, K., and ten Dijke, P. (1997). TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
41. Henis, Y. I., Moustakas, A., Lin, H. Y., and Lodish, H. F. (1994). The types II and III transforming growth factor-β receptors form homo-oligomers. J. Cell Biol. 126, 139-154.
42. Hinck, A. P., Archer, S. J., Qian, S. W., Roberts, A. B., Sporn, M. B., Weatherbee, J. A., Tsang, M. L., Lucas, R., Zhang, B. L., Wenker, J., and Torchia, D. A. (1996). Transforming growth factor β 1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor β2. Biochemistry 35, 8517-8534.
43. Hogan, B. L. (1996). Bone morphogenetic proteins in development. Curr. Opin. Genet. Dev. 6, 432-438.
44. Huang, S. S., Liu, Q., Johnson, F. E., Konish, Y., and Huang, J. S. (1997). Transforming growth factor β peptide antagonists and their conversion to partial agonists. J. Biol. Chem. 272, 27155-27159.
45. Huse, M., Chen, Y. G., Massague, J., and Kuriyan, J. (1999). Crystal structure of the cytoplasmic domain of the type I TGFβ receptor in complex with FKBP12. Cell 96, 425-436.
46. Katagiri, T., Boorla, S., Frendo, J. L., Hogan, B. L., and Karsenty, G. (1998). Skeletal abnormalities in doubly heterozygous Bmp4 and Bmp7 mice. Dev. Genet. 22, 340-348.
47. Keller, S., Nickel, J., Zhang, J. L., Sebald, W., and Mueller, T. D. (2004). Molecular recognition of BMP-2 and BMP receptor IA. Nat. Struct. Mol. Biol. 11, 481-488.
48. Kim, M., Carman, C. V., and Springer, T. A. (2003). Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301, 1720-1725.
49. Kingsley, D. M. (1994). What do BMPs do in mammals? Clues from the mouse short-ear mutation. Trends Genet. 10, 16-21.
50. Kirsch, T., Nickel, J., and Sebald, W. (2000a). BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. EMBO J. 19, 3314-3324.
51. Kirsch, T., Sebald, W., and Dreyer, M. K. (2000b). Crystal structure of the BMP-2-BRIA ectodomain complex. Nat. Struct. Biol. 7, 492-496.
52. Knaus, P., and Sebald, W. (2001). Cooperativity of binding epitopes and receptor chains in the BMP/TGFβ superfamily. Biol. Chem. 382, 1189-1195.
53. Koenig, B. B., Cook, J. S., Wolsing, D. H., Ting, J., Tiesman, J. P., Correa, P. E., Olson, C. A., Pecquet, A. L., Ventura, F., Grant, R. A., and et al. (1994). Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol. Cell. Biol. 14, 5961-5974.
54. Kusu, N., Laurikkala, J., Imanishi, M., Usui, H., Konishi, M., Miyake, A., Thesleff, I., and Itoh, N. (2003). Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. J. Biol. Chem. 278, 24113-24117.
55. Lapthorn, A. J., Harris, D. C., Littlejohn, A., Lustbader, J. W., Canfield, R. E., Machin, K. J., Morgan, F. J., and Isaacs, N. W. (1994). Crystal structure of human chorionic gonadotropin. Nature 369, 455-461.
56. Larrain, J., Bachiller, D., Lu, B., Agius, E., Piccolo, S., and De Robertis, E. M. (2000). BMP-binding modules in chordin: a model for signalling regulation in the extracellular space. Development 127, 821-830.
57. Larrain, J., Oelgeschlager, M., Ketpura, N. I., Reversade, B., Zakin, L., and De Robertis, E. M. (2001). Proteolytic cleavage of Chordin as a switch for the dual activities of Twisted gastrulation in BMP signaling. Development 128, 4439-4447.
58. Lee, S. J., and McPherron, A. C. (2001). Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. USA 98, 9306-9311.
59. Letzelter, F., Wang, Y., and Sebald, W. (1998). The interleukin-4 site-2 epitope determining binding of the common receptor γ chain. Eur. J. Biochem. 257, 11-20.
60. Lewis, K. A., Gray, P. C., Blount, A. L., MacConell, L. A., Wiater, E., Bilezikjian, L. M., and Vale, W. (2000). Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404, 411-414.
61. Liu, F., Ventura, F., Doody, J., and Massague, J. (1995). Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol. 15, 3479-3486.
62. Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., and Wilson, I. A. (1999). Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283, 987-990.
63. Lo, R. S., and Massague, J. (1999). Ubiquitin-dependent degradation of TGF-β-activated smad2. Nat. Cell Biol. 1, 472-478.
64. Luo, K., and Lodish, H. F. (1997). Positive and negative regulation of type II TGF-β receptor signal transduction by autophosphorylation on multiple serine residues. EMBO J. 16, 1970-1981.
65. Macias-Silva, M., Hoodless, P. A., Tang, S. J., Buchwald, M., and Wrana, J. L. (1998). Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273, 25628-25636.
66. Massague, J. (1998). TGF-β signal transduction. Annu. Rev. Biochem. 67, 753-791.
67. Massague, J., and Chen, Y. G. (2000). Controlling TGF-β signaling. Genes Dev. 14, 627-644.
68. Massague, J., Attisano, L., and Wrana, J. L. (1994). The TGF-β family and its composite receptors. Trends Cell Biol. 4, 172-178.
69. Massague, J., Blain, S. W., and Lo, R. S. (2000). TGF-β signaling in growth control, cancer, and heritable disorders. Cell 103, 295-309.
70. McDonald, N. Q., and Hendrickson, W. A. (1993). A structural superfamily of growth factors containing a cystine knot motif. Cell 73, 421-424.
71. McDonald, N. Q., Lapatto, R., Murray-Rust, J., Gunning, J., Wlodawer, A., and Blundell, T. L. (1991). New protein fold revealed by a 2.3-Å resolution crystal structure of nerve growth factor. Nature 354, 411-414.
72. Mittl, P. R., Priestle, J. P., Cox, D. A., McMaster, G., Cerletti, N., and Grutter, M. G. (1996). The crystal structure of TGF-β 3 and comparison to TGF-β 2: implications for receptor binding. Protein Sci. 5, 1261-1271.
73. Miyazono, K., Kusanagi, K., and Inoue, H. (2001). Divergence and convergence of TGF-β/BMP signaling. J. Cell Physiol. 187, 265-276.
74. Miyazono, K., ten Dijke, P., and Heldin, C. H. (2000). TGF-β signaling by Smad proteins. Adv. Immunol. 75, 115-157.
75. Mortlock, D. P., Guenther, C., and Kingsley, D. M. (2003). A general approach for identifying distant regulatory elements applied to the Gdf6 gene. Genome Res. 13, 2069-2081.
76. Moustakas, A., Souchelnytskyi, S., and Heldin, C. H. (2001). Smad regulation in TGF-β signal transduction. J. Cell Sci. 114, 4359-4369.
77. Muller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., and de Vos, A. M. (1997). Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc. Natl. Acad. Sci. USA 94, 7192-7197.
78. Nakamura, K., Shirai, T., Morishita, S., Uchida, S., Saeki-Miura, K., and Makishima, F. (1999). p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells. Exp. Cell Res. 250, 351-363.
79. Newfeld, S. J., Wisotzkey, R. G., and Kumar, S. (1999). Molecular evolution of a developmental pathway: phylogenetic analyses of transforming growth factor-β family ligands, receptors and Smad signal transducers. Genetics 152, 783-795.
80. Nishitoh, H., Ichijo, H., Kimura, M., Matsumoto, T., Makishima, F., Yamaguchi, A., Yamashita, H., Enomoto, S., and Miyazono, K. (1996). Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J. Biol. Chem. 271, 21345-21352.
81. Nohe, A., Hassel, S., Ehrlich, M., Neubauer, F., Sebald, W., Henis, Y. I., and Knaus, P. (2002). The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem. 277, 5330-5338.
82. Nohno, T., Ishikawa, T., Saito, T., Hosokawa, K., Noji, S., Wolsing, D. H., and Rosenbaum, J. S. (1995). Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J. Biol. Chem. 270, 22522-22526.
83. Oelgeschlager, M., Reversade, B., Larrain, J., Little, S., Mullins, M. C., and De Robertis, E. M. (2003). The pro-BMP activity of Twisted gastrulation is independent of BMP binding. Development 130, 4047-4056.
84. Ohkawara, B., Iemura, S., ten Dijke, P., and Ueno, N. (2002). Action range of BMP is defined by its N-terminal basic amino acid core. Curr. Biol. 12, 205-209.
85. Onichtchouk, D., Chen, Y. G., Dosch, R., Gawantka, V., Delius, H., Massague, J., and Niehrs, C. (1999). Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature 401, 480-485.
86. Paques, M., Massin, P., and Gaudric, A. (1997). Growth factors and diabetic retinopathy. Diabetes Metab. 23, 125-130.
87. Patterson, G. I., and Padgett, R. W. (2000). TGF β-related pathways. Roles in Caenorhabditis elegans development. Trends Genet. 16, 27-33.
88. Piek, E., Afrakhte, M., Sampath, K., van Zoelen, E. J., Heldin, C. H., and ten Dijke, P. (1999). Functional antagonism between activin and osteogenic protein-1 in human embryonal carcinoma cells. J. Cell Physiol. 180, 141-149.
89. Rebbapragada, A., Benchabane, H., Wrana, J. L., Celeste, A. J., and Attisano, L. (2003). Myostatin signals through a transforming growth factor β-like signaling pathway to block adipogenesis. Mol. Cell. Biol. 23, 7230-7242.
90. Reddi, A. H. (1998). Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat. Biotechnol. 16, 247-252.
91. Rosen, V., and Thies, R. S. (1992). The BMP proteins in bone formation and repair. Trends Genet. 8, 97-102.
92. Rotzer, D., Roth, M., Lutz, M., Lindemann, D., Sebald, W., and Knaus, P. (2001). Type III TGF-β receptor-independent signalling of TGF-β2 via TβRII-B, an alternatively spliced TGF-β type II receptor. EMBO J. 20, 480-490.
93. Ruppert, R., Hoffmann, E., and Sebald, W. (1996). Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 237, 295-302.
94. Scheufler, C., Sebald, W., and Hulsmeyer, M. (1999). Crystal structure of human bone morphogenetic protein-2 at 2.7 Å resolution. J. Mol. Biol. 287, 103-115.
95. Schlessinger, J. (1988). Signal transduction by allosteric receptor oligomerization. Trends Biochem. Sci. 13, 443-447.
96. Schlessinger, J., Lax, I., and Lemmon, M. (1995). Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 83, 357-360.
97. Schlunegger, M. P., and Grutter, M. G. (1992). An unusual feature revealed by the crystal structure at 2.2 Å resolution of human transforming growth factor-β 2. Nature 358, 430-434.
98. Sebald, W., and Mueller, T. D. (2003). The interaction of BMP-7 and ActRII implicates a new mode of receptor assembly. Trends Biochem. Sci. 28, 518-521.
99. Settle, S. H., Jr., Rountree, R. B., Sinha, A., Thacker, A., Higgins, K., and Kingsley, D. M. (2003). Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev. Biol. 254, 116-130.
100. Shi, Y., and Massague, J. (2003). Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700.
101. Solloway, M. J., and Robertson, E. J. (1999). Early embryonic lethality in Bmp5;Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development 126, 1753-1768.
102. Souchelnytskyi, S., Moustakas, A., and Heldin, C. H. (2002). TGF-β signaling from a three-dimensional perspective: insight into selection of partners. Trends Cell Biol. 12, 304-307.
103. Stahl, N., and Yancopoulos, G. D. (1993). The alphas, betas, and kinases of cytokine receptor complexes. Cell 74, 587-590.
104. Stelzer, C., Winterpacht, A., Spranger, J., and Zabel, B. (2003). Grebe dysplasia and the spectrum of CDMP1 mutations. Pediatr. Pathol. Mol. Med. 22, 77-85.
105. Storm, E. E., and Kingsley, D. M. (1996). Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 122, 3969-3979.
106. Syed, R. S., Reid, S. W., Li, C., Cheetham, J. C., Aoki, K. H., Liu, B., Zhan, H., Osslund, T. D., Chirino, A. J., Zhang, J. et al. (1998). Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395, 511-516.
107. ten Dijke, P., Yamashita, H., Sampath, T. K., Reddi, A. H., Estevez, M., Riddle, D. L., Ichijo, H., Heldin, C. H., and Miyazono, K. (1994). Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269, 16985-16988.
108. ten Dijke, P., Miyazono, K., and Heldin, C. H. (1996). Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr. Opin. Cell Biol. 8, 139-145.
109. Thomas, J. T., Kilpatrick, M. W., Lin, K., Erlacher, L., Lembessis, P., Costa, T., Tsipouras, P., and Luyten, F. P. (1997). Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1. Nat. Genet. 17, 58-64.
110. Thompson, T. B., Woodruff, T. K., and Jardetzky, T. S. (2003). Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-β ligand:receptor interactions. EMBO J. 22, 1555-1566.
111. Turgeman, G., Zilberman, Y., Zhou, S., Kelly, P., Moutsatsos, I. K., Kharode, Y. P., Borella, L. E., Bex, F. J., Komm, B. S., Bodine, P. V., and Gazit, D. (2002). Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice. J. Cell Biochem. 86, 461-474.
112. Warren, S. M., Brunet, L. J., Harland, R. M., Economides, A. N., and Longaker, M. T. (2003). The BMP antagonist noggin regulates cranial suture fusion. Nature 422, 625-629.
113. Weis Garcia, F., and Massague, J. (1996). Complementation between kinase-defective and activation-defective TGF-β receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15, 276-289.
114. Wells, J. A., Cunningham, B. C., Fuh, G., Lowman, H. B., Bass, S. H., Mulkerrin, M. G., Ultsch, M., and deVos, A. M. (1993). The molecular basis for growth hormone-receptor interactions. Recent Prog. Horm. Res. 48, 253-275.
115. Wiater, E., and Vale, W. (2003). Inhibin is an antagonist of bone morphogenetic protein signaling. J. Biol. Chem. 278, 7934-7941.
116. Wieser, R., Wrana, J. L., and Massague, J. (1995). GS domain mutations that constitutively activate T β R-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14, 2199-2208.
117. Winkler, D. G., Sutherland, M. K., Geoghegan, J. C., Yu, C., Hayes, T., Skonier, J. E., Shpektor, D., Jonas, M., Kovacevich, B. R., Staehling-Hampton, K. et al. (2003). Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 22, 6267-6276.
118. Woodcock, J. M., Bagley, C. J., Zacharakis, B., and Lopez, A. F. (1996). A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common β-chain is necessary and sufficient for high affinity binding and signaling by all three ligands. J. Biol. Chem. 271, 25999-26006.
119. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. (1994). Mechanism of activation of the TGF-Β receptor. Nature 370, 341-347.
120. Wu, X. B., Li, Y., Schneider, A., Yu, W., Rajendren, G., Iqbal, J., Yamamoto, M., Alam, M., Brunet, L. J., Blair, H. C. et al. (2003). Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J. Clin. Invest. 112, 924-934.
121. Wuytens, G., Verschueren, K., de Winter, J. P., Gajendran, N., Beek, L., Devos, K., Bosman, F., de Waele, P., Andries, M., van den Eijnden van Raaij, A. J. et al. (1999). Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptors. J. Biol. Chem. 274, 9821-9827.
122. Xiong, J. P., Stehle, T., Zhang, R., Joachimiak, A., Frech, M., Goodman, S. L., and Arnaout, M. A. (2002). Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand. Science 296, 151-155.
123. Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., and Matsumoto, K. (1995). Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270, 2008-2011.
124. Yi, S. E., Daluiski, A., Pederson, R., Rosen, V., and Lyons, K. M. (2000). The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 127, 621-630.
125. Yoshimura, Y., Nomura, S., Kawasaki, S., Tsutsumimoto, T., Shimizu, T., and Takaoka, K. (2001). Colocalization of noggin and bone morphogenetic protein-4 during fracture healing. J. Bone Miner. Res. 16, 876-884.
126. Yu, M., Wu, P., Widelitz, R. B., and Chuong, C. M. (2002). The morphogenesis of feathers. Nature 420, 308-312.
127. Zhu, H., Kavsak, P., Abdollah, S., Wrana, J. L., and Thomsen, G. H. (1999). A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687-693.
128. Zimmerman, L. B., De Jesus Escobar, J. M., and Harland, R. M. (1996). The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86, 599-606.
129. Zimmers, T. A., Davies, M. V., Koniaris, L. G., Haynes, P., Esquela, A. F., Tomkinson, K. N., McPherron, A. C., Wolfman, N. M., and Lee, S. J. (2002). Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486-1488.